- Chronic lymphocytic leukemia and concurrent seminoma in the same testis
-
Miyai K, Kumazawa F, Sato K, Tsuda H
- KMID: 2524229
- J Pathol Transl Med.
- 2022 Jan;56(1):48-52.
- doi: 10.4132/jptm.2021.09.10
A 59-year-old man presented with a painless testicular mass and underwent a radical orchiectomy. The resected specimen showed a 5-cm-sized, white-yellow and homogenous solid mass in the testicular parenchyma. Histologically,... -
- CITED
-
- Close
- SHARE
-
- Close
- Activated Protein C Anticoagulant System Dysfunction and Thrombophilia in Asia
-
Hamasaki N, Kuma H, Tsuda H
- KMID: 1781292
- Ann Lab Med.
- 2013 Jan;33(1):8-13.
- doi: 10.3343/alm.2013.33.1.8
Thrombophilia that is common among Caucasians is caused by genetic polymorphisms of coagulation factor V Leiden (R506Q) and prothrombin G20210A. Unlike that in Caucasians, thrombophilia that is common in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2404015
- J Gynecol Oncol.
- 2018 Mar;29(2):e20.
- doi: 10.3802/jgo.2018.29.e20
OBJECTIVE: In 2014 World Health Organization criteria, seromucinous carcinoma was defined as a new histological subtype in ovarian carcinomas, but “seromucinous carcinoma†was not defined in endometrial carcinomas. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Presentation of Cervical Myelopathy at C1-2 Level
-
Murahashi , Takebayashi T, Terashima , Tsuda H, Yoshimoto , Yamashita
- KMID: 2349301
- Asian Spine J.
- 2016 Aug;10(4):755-761.
- doi: 10.4184/asj.2016.10.4.755
STUDY DESIGN: Single-center retrospective study. PURPOSE: To clarify the clinical features of cervical myelopathy at the C1-2 level. OVERVIEW OF LITERATURE: Methods for distinguishing the affected level based on myelomere symptoms or... -
- CITED
-
- Close
- SHARE
-
- Close
- Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells
-
Nakamura M, Ozaki T, Ishii A, Konishi M, Tsubota Y, Furui T, Tsuda H, Mori I, Ota K, Kakudo K
- KMID: 1123804
- Exp Mol Med.
- 2009 May;41(5):307-314.
- doi: 10.3858/emm.2009.41.5.034
Calcitonin (CT), a polypeptide hormone, plays important roles in a variety of physiological processes. CT has been used clinically to treat osteoporosis and humoral hypercalcemia of malignancy. In order to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review
-
Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Tsuda H, Furuya K
- KMID: 2288559
- J Gynecol Oncol.
- 2013 Jan;24(1):37-43.
- doi: 10.3802/jgo.2013.24.1.37
OBJECTIVE: Compared with serous adenocarcinoma (SAC), clear cell carcinoma (CCC) often shows chemo-resistance, which would potentially lead to a poor prognosis. On the other hand, there have been arguments over... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2413444
- J Gynecol Oncol.
- 2017 May;28(3):e33.
- doi: 10.3802/jgo.2017.28.e33
OBJECTIVE: Ovarian clear cell carcinoma (CCC) is one of histological subtypes showing poor prognosis due to chemoresistance. The association of autophagy-related proteins and clinical implementation in CCC has not been... -
- CITED
-
- Close
- SHARE
-
- Close
- DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
-
Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K
- KMID: 2158801
- J Gynecol Oncol.
- 2015 Jan;26(1):40-45.
- doi: 10.3802/jgo.2015.26.1.40
OBJECTIVE: Recent investigations have revealed DNA mismatch repair (MMR) gene mutations are closely related with carcinogenesis of endometrial cancer; however the impact of MMR protein expression on prognosis is not... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
